A detailed history of Cibc Asset Management Inc transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 342,126 shares of LBPH stock, worth $6.46 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
342,126
Previous 212,178 61.24%
Holding current value
$6.46 Million
Previous $1.28 Million 477.72%
% of portfolio
0.03%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$18.89 - $26.06 $2.45 Million - $3.39 Million
129,948 Added 61.24%
342,126 $7.39 Million
Q4 2023

Feb 13, 2024

BUY
$3.68 - $6.5 $248,793 - $439,445
67,607 Added 46.76%
212,178 $1.28 Million
Q2 2023

Aug 14, 2023

BUY
$4.19 - $10.05 $370,588 - $888,882
88,446 Added 157.59%
144,571 $1.06 Million
Q1 2023

May 12, 2023

BUY
$3.84 - $5.96 $215,520 - $334,505
56,125 New
56,125 $225,000

Others Institutions Holding LBPH

About Longboard Pharmaceuticals, Inc.


  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $256M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.